Physician profile
William S Moscow
NPI 1144390600
$8,457.14
in general payments reported to CMS, 2019-2025
17 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,406 · 2020: $506 · 2021: $1,728 · 2022: $1,478 · 2023: $771 · 2024: $1,143 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,154 · Entertainment: $115 · Gift: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,154.01 |
| Entertainment | $114.67 |
| Gift | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $3,434.02 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,188.89 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $1,102.52 | 2022-2025 | Infuse |
| Sight Sciences, INC. | $549.63 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $332.58 | 2021-2024 | Cequa |
| Johnson & Johnson Vision Care, INC. | $282.91 | 2021-2023 | Acuvue |
| Optos, INC. | $270.81 | 2019-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Visioneering Technologies, INC. | $263.39 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $206.49 | 2019-2021 | |
| Dompe US, INC. | $197.72 | 2022-2024 | Oxervate |
| Glaukos Corporation | $147.33 | 2023 | |
| Harrow Eye, LLC | $125.18 | 2025 | Vevye |
| Lkc Technologies, INC. | $99.61 | 2025 | |
| Abb Con-Cise Optical Group LLC | $88.35 | 2020-2022 | |
| Oyster Point Pharma, INC. | $82.47 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $51.50 | 2019-2022 | |
| Shire North American Group INC | $33.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Moscow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.